Amparo Escribano Montaner-rekin lankidetzan egindako argitalpenak (11)

2020

  1. Recurrent wheezing during the first 3 years of life in a birth cohort of moderate-to-late preterm infants

    Pediatric Allergy and Immunology, Vol. 31, Núm. 2, pp. 124-132

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  2. Cystic fibrosis treatment: targeting the basic defect

    Expert Opinion on Orphan Drugs, Vol. 5, Núm. 2, pp. 181-192

  3. Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period

    mBio, Vol. 8, Núm. 5

2016

  1. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

    Journal of Cystic Fibrosis, Vol. 15, Núm. 3, pp. 357-365

  2. Emergence of cfr-mediated linezolid resistance in a methicillin-resistant Staphylococcus aureus epidemic clone isolated from patients with cystic fibrosis

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 3, pp. 1878-1882

2015

  1. Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of life

    Pediatric Allergy and Immunology, Vol. 26, Núm. 8, pp. 797-804

2003

  1. Clinical characteristics of the fatal and near-fatal asthma in Alternaria alternata sensitized patients

    Medicina Clinica, Vol. 121, Núm. 19, pp. 721-724

2002

  1. Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma

    European Respiratory Journal, Vol. 19, Núm. 5, pp. 846-852

2001

  1. Guidelines for diagnosing and treating respiratory involvement in cystic fibrosis

    Archivos de Bronconeumologia, Vol. 37, Núm. 8, pp. 316-324

  2. Nebulized antibiotics patients with cystic fibrosis

    Medicina Clinica